Disruptions to the intestinal microbiome during weaning lead to long-term negative effects on host immune function. However, the critical host-microbe interactions occurring during weaning required for healthy immune system development remain poorly understood. We find that restricting microbiome maturation during weaning leads to stunted immune system development and increased susceptibility to enteric infection. We developed a gnotobiotic mouse model of the early-life microbiome designated as Pediatric Community (PedsCom). This nine-member consortium of microbes derived from intestinal microbiomes of preweaning mice stably colonized germfree adult mice and was efficiently transmitted to offspring for multiple generations. Unexpectedly, the relative abundance of PedsCom microbes were largely unaffected by the transition from a milk-based to a fiber rich solid food diet. PedsCom mice developed less peripheral regulatory T cells and Immunoglobulin A, hallmarks of microbiota-driven immune system development. Consistent with defects in maturation, adult PedsCom mice retain high susceptibility to salmonella infection characteristic of young mice and humans. Altogether, our work illustrates how the post-weaning transition in intestinal microbiome composition contributes to normal immune maturation and protection from enteric infection. Accurate modelling of the pre-weaning microbiome provides a window into the microbial requirements of healthy immune development and suggests an opportunity to design microbial interventions at weaning to improve immune system development in human infants.
SARS-CoV-2 vaccination is highly effective at reducing viral infection, hospitalization and death. However, vaccine breakthrough infections have been widely observed, raising the question of whether particular viral variants or viral mutations are associated with breakthrough.
We report the genome of a B.1.1.7+E484K SARS-CoV-2 from southeastern Pennsylvania and compare to all high-coverage B.1.1.7+E484K genomes (n=235) available. Analyses showed the existence of at least 4 distinct clades of this variant circulating in the US, and the possibility of at least 59 independent acquisitions of the E484K mutation.
Mammals produce large quantities of mucosal and systemic antibodies that maintain the
intestinal barrier, shape the intestinal microbiome and promote lifelong mutualism with
commensal microbes. Here, we developed an integrated host-commensal approach
combining microbial flow cytometry and 16s rRNA gene sequencing to define the core
microbes that induce mucosal and systemic antibodies in pediatric selective
Immunoglobulin A (IgA) deficient and household control siblings with CyTOF analysis to
determine the impacts of IgA deficiency on host cellular immune phenotype. In healthy
controls, mucosal secretory IgA and IgM antibodies coat an overlapping subset of
microbes, predominantly Firmicutes and Proteobacteria. Serum IgG antibodies target a
similar consortium of fecal microbes, revealing connections between mucosal and
systemic antibody networks. Unexpectedly, IgM provides limited compensation for IgA in
children lacking intestinal IgA. Furthermore, we find broad systemic immune
dysregulation in a subset of children and mice lacking IgA, including enhanced IgG
targeting of fecal microbiota, elevated levels of inflammatory and allergic cytokines and
alterations in T cell activation state. Thus, IgA tunes systemic interactions between the
host and commensal microbiota. Understanding how IgA tunes baseline immune tone
has implications for predicting and preventing autoimmune, inflammatory and allergic
diseases broadly, as well as providing improved prognostic guidance to patients with IgA
deficiency.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.